Back to today’s briefing

Story perspectives

Investors Eye Promising Stocks: AstraZeneca, Uber, Zoom

1/11/2025

42 7

Summary

Story summary

With 2025 on the horizon, it's time for investors to reassess their portfolios. AstraZeneca is pioneering targeted cancer therapies, Uber is riding a wave of impressive revenue growth, and Zoom is enhancing its videoconferencing capabilities. Despite recent setbacks, these undervalued stocks hold promising potential for long-term gains.

1 of 1

Story summary

With 2025 on the horizon, it's time for investors to reassess their portfolios. AstraZeneca is pioneering targeted cancer therapies, Uber is riding a wave of impressive revenue growth, and Zoom is enhancing its videoconferencing capabilities. Despite recent setbacks, these undervalued stocks hold promising potential for long-term gains.